Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 16 Researches
7.7
USERS' SCORE
Moderately Good
Based on 14 Reviews
7.7
Supplement Facts
Serving Size: 2 Softgels
Amount Per Serving
%DV
Calories
25
Total Fat
2 g
3%*
Polyunsaturated Fat
1 g
†
Sunflower Lecithin
2.4 g (2,400 mg)
†
Phosphatidyl Choline
360 mg
†
Top Medical Research Studies
8
We aimed to investigate how 4-farnesyloxycoumarin (4-FLC) loaded in liposomal nanoparticles (4-FLC-LNPs) affects breast cancer. The study included assessing toxicity against the MCF-7 breast cancer cell line, and our findings revealed that 4-FLC-LNPs had a notable cytotoxic effect, with an IC50 value of around 60 μg/mL.
We observed that these nanoparticles not only promote cell death but also hinder cancer spread, as shown by increased apoptosis rates and changes in specific protein expressions. While the results are promising, further preclinical studies are necessary to fully explore their therapeutic potential.
We observed that these nanoparticles not only promote cell death but also hinder cancer spread, as shown by increased apoptosis rates and changes in specific protein expressions. While the results are promising, further preclinical studies are necessary to fully explore their therapeutic potential.
9
We explored the effect of copper nanoparticles (CuNPs) encased in soya lecithin liposomes on breast cancer cells. This study showed that the encapsulated form was more effective than free CuNPs in combating cancer in vitro, with improved cytotoxicity observed.
The testing included analyzing the characteristics of both forms and assessing their ability to target cancer cells. While the combined delivery system demonstrated potential benefits, the overall findings suggest a need for further investigation before concluding its efficacy in real-world scenarios.
The testing included analyzing the characteristics of both forms and assessing their ability to target cancer cells. While the combined delivery system demonstrated potential benefits, the overall findings suggest a need for further investigation before concluding its efficacy in real-world scenarios.
9
We investigated a novel cancer treatment utilizing a nanogenerator that releases nitric oxide and alkyl radicals when exposed to a near-infrared laser. This method, which combines the properties of these two agents, showed a promising way to inhibit breast tumor growth.
The findings indicated that this approach caused cancer cell death through a mitochondria-mediated pathway, which was enhanced by the controlled release of these radicals. Overall, while the study offers a fresh perspective on breast cancer treatment, its real-world application is still under exploration.
The findings indicated that this approach caused cancer cell death through a mitochondria-mediated pathway, which was enhanced by the controlled release of these radicals. Overall, while the study offers a fresh perspective on breast cancer treatment, its real-world application is still under exploration.
Most Useful Reviews
9
Improved milk flow
1 people found this helpful
After trying it for a few days, I placed another bottle in my cart. I can't imagine my breastfeeding journey without it; my milk flow is much better now, and I have fewer clogged ducts.
9
Eliminated mastitis
1 people found this helpful
I have been taking this for over six months on my doctor's recommendation. While breastfeeding, I occasionally experienced mastitis in one breast. Since I started taking this, the problem has been resolved completely! I highly recommend it for breastfeeding mothers.
7.5
Thickens milk
5 people found this helpful
I bought it to thicken breast milk, and it has indeed helped me, thank God. I've repurchased it due to its other benefits, but the primary reason remains its effectiveness in enhancing milk thickness.
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 16 Researches
7.7
- All Researches
9
We explored the effect of copper nanoparticles (CuNPs) encased in soya lecithin liposomes on breast cancer cells. This study showed that the encapsulated form was more effective than free CuNPs in combating cancer in vitro, with improved cytotoxicity observed.
The testing included analyzing the characteristics of both forms and assessing their ability to target cancer cells. While the combined delivery system demonstrated potential benefits, the overall findings suggest a need for further investigation before concluding its efficacy in real-world scenarios.
The testing included analyzing the characteristics of both forms and assessing their ability to target cancer cells. While the combined delivery system demonstrated potential benefits, the overall findings suggest a need for further investigation before concluding its efficacy in real-world scenarios.
9
We investigated a novel cancer treatment utilizing a nanogenerator that releases nitric oxide and alkyl radicals when exposed to a near-infrared laser. This method, which combines the properties of these two agents, showed a promising way to inhibit breast tumor growth.
The findings indicated that this approach caused cancer cell death through a mitochondria-mediated pathway, which was enhanced by the controlled release of these radicals. Overall, while the study offers a fresh perspective on breast cancer treatment, its real-world application is still under exploration.
The findings indicated that this approach caused cancer cell death through a mitochondria-mediated pathway, which was enhanced by the controlled release of these radicals. Overall, while the study offers a fresh perspective on breast cancer treatment, its real-world application is still under exploration.
8
We aimed to investigate how 4-farnesyloxycoumarin (4-FLC) loaded in liposomal nanoparticles (4-FLC-LNPs) affects breast cancer. The study included assessing toxicity against the MCF-7 breast cancer cell line, and our findings revealed that 4-FLC-LNPs had a notable cytotoxic effect, with an IC50 value of around 60 μg/mL.
We observed that these nanoparticles not only promote cell death but also hinder cancer spread, as shown by increased apoptosis rates and changes in specific protein expressions. While the results are promising, further preclinical studies are necessary to fully explore their therapeutic potential.
We observed that these nanoparticles not only promote cell death but also hinder cancer spread, as shown by increased apoptosis rates and changes in specific protein expressions. While the results are promising, further preclinical studies are necessary to fully explore their therapeutic potential.
8
Lecithin nanoparticles show promise
We explored a new method for treating breast cancer by using lecithin-based nanoparticles loaded with Palbociclib (PALB). These particles are uniquely designed to release the drug in a pH-sensitive manner, showing promise in lab studies by significantly reducing cancer cell growth compared to Palbociclib alone.
We noted improvements in drug delivery that led to increased cell death and reduced migration of cancer cells. However, while the results are promising, it’s important to conduct further research to confirm these effects in actual clinical settings.
We noted improvements in drug delivery that led to increased cell death and reduced migration of cancer cells. However, while the results are promising, it’s important to conduct further research to confirm these effects in actual clinical settings.
8
We explored a promising approach to breast cancer treatment using lipid-polymer hybrid nanoparticles that deliver sunitinib malate, a recognized anticancer drug. By stabilizing the formulation with lecithin, we optimized a nanoparticle (SLPN4) that demonstrated enhanced drug release compared to the pure drug. Notably, SLPN4 showed significant cytotoxic effects on breast cancer cells in laboratory tests. These findings suggest that this lecithin-based strategy could be an effective option for improving breast cancer therapies.
User Reviews
USERS' SCORE
Moderately Good
Based on 14 Reviews
7.7
- All Reviews
- Positive Reviews
- Negative Reviews
9
Improved milk flow
1 people found this helpful
After trying it for a few days, I placed another bottle in my cart. I can't imagine my breastfeeding journey without it; my milk flow is much better now, and I have fewer clogged ducts.
9
Eliminated mastitis
1 people found this helpful
I have been taking this for over six months on my doctor's recommendation. While breastfeeding, I occasionally experienced mastitis in one breast. Since I started taking this, the problem has been resolved completely! I highly recommend it for breastfeeding mothers.
7.5
Thickens milk
5 people found this helpful
I bought it to thicken breast milk, and it has indeed helped me, thank God. I've repurchased it due to its other benefits, but the primary reason remains its effectiveness in enhancing milk thickness.
7.5
Unclogs ducts
4 people found this helpful
This seems to be effective for me. After reading articles and reviews on blocked ducts, I've noticed a significant improvement. Milk flows much better now, eliminating engorgement and blocked ducts.
6
Increases milk supply
2 people found this helpful
This product is excellent as it provides breast milk and contains soy, which I believe helps to increase my milk supply.
Frequently Asked Questions
9
Improved milk flow
1 people found this helpful
After trying it for a few days, I placed another bottle in my cart. I can't imagine my breastfeeding journey without it; my milk flow is much better now, and I have fewer clogged ducts.
9
Eliminated mastitis
1 people found this helpful
I have been taking this for over six months on my doctor's recommendation. While breastfeeding, I occasionally experienced mastitis in one breast. Since I started taking this, the problem has been resolved completely! I highly recommend it for breastfeeding mothers.
7.5
Effective for clogs
1 people found this helpful
I intend to repurchase this as it has effectively addressed breast clogs when combined with massage and more frequent feeding. I plan to continue using it for the entire breastfeeding period.
6
Increases fat content
1 people found this helpful
This product significantly increases the fat content in my breast milk, meaning I need to feed less often than usual—it's been a positive change.
4
Minimal impact
Many people claim it reduces breast blockage after use, but for me, it hasn’t made much of a difference.
8
We investigated how lecithin, particularly when combined with curcumin, affects breast cancer cells. The study focused on chitosan-coated nanoliposomes made from three sources of lecithin.
Our findings revealed that salmon lecithin had the most significant growth-inhibitory effect on MCF-7 breast cancer cells, showing two to four times lower growth compared to the control group. Both soya and rapeseed lecithins also demonstrated notable effects.
Overall, while curcumin encapsulated in these liposomes proved promising, there was no indication it would surpass the limitations of current anticancer treatments.
Our findings revealed that salmon lecithin had the most significant growth-inhibitory effect on MCF-7 breast cancer cells, showing two to four times lower growth compared to the control group. Both soya and rapeseed lecithins also demonstrated notable effects.
Overall, while curcumin encapsulated in these liposomes proved promising, there was no indication it would surpass the limitations of current anticancer treatments.
8
We explored the impact of Pterostilbene (PTE) nanoparticles on breast cancer treatment. By using soybean lecithin as a stabilizer, we created nanoparticles that significantly improved the solubility of PTE. Our experiments showed that these nanoparticles boosted anti-cancer activity, outperforming free PTE by four to eight times against various breast cancer cell lines.
When tested in tumor-bearing mice, the PTE-nanoparticles matched the therapeutic effectiveness of established treatments. These findings suggest that PTE nanoparticles could be a promising option for enhancing breast cancer therapies.
When tested in tumor-bearing mice, the PTE-nanoparticles matched the therapeutic effectiveness of established treatments. These findings suggest that PTE nanoparticles could be a promising option for enhancing breast cancer therapies.
8
We explored a promising approach to breast cancer treatment using lipid-polymer hybrid nanoparticles that deliver sunitinib malate, a recognized anticancer drug. By stabilizing the formulation with lecithin, we optimized a nanoparticle (SLPN4) that demonstrated enhanced drug release compared to the pure drug. Notably, SLPN4 showed significant cytotoxic effects on breast cancer cells in laboratory tests. These findings suggest that this lecithin-based strategy could be an effective option for improving breast cancer therapies.
7
Hybrid nanoparticles improve Apigenin delivery
We observed the development of hybrid nanoparticles using a natural compound, Apigenin, combined with lecithin for breast cancer treatment.
These nanoparticles were optimized for their size and effectiveness, showcasing promising results.
They demonstrated smaller sizes and better drug release rates compared to Apigenin alone, showing 61.5% release over 24 hours.
Additionally, these nanoparticles showed increased antioxidant activity and cytotoxicity against cancer cells, suggesting a potential benefit in breast cancer therapy.
These nanoparticles were optimized for their size and effectiveness, showcasing promising results.
They demonstrated smaller sizes and better drug release rates compared to Apigenin alone, showing 61.5% release over 24 hours.
Additionally, these nanoparticles showed increased antioxidant activity and cytotoxicity against cancer cells, suggesting a potential benefit in breast cancer therapy.
8
We aimed to investigate how 4-farnesyloxycoumarin (4-FLC) loaded in liposomal nanoparticles (4-FLC-LNPs) affects breast cancer. The study included assessing toxicity against the MCF-7 breast cancer cell line, and our findings revealed that 4-FLC-LNPs had a notable cytotoxic effect, with an IC50 value of around 60 μg/mL.
We observed that these nanoparticles not only promote cell death but also hinder cancer spread, as shown by increased apoptosis rates and changes in specific protein expressions. While the results are promising, further preclinical studies are necessary to fully explore their therapeutic potential.
We observed that these nanoparticles not only promote cell death but also hinder cancer spread, as shown by increased apoptosis rates and changes in specific protein expressions. While the results are promising, further preclinical studies are necessary to fully explore their therapeutic potential.
8
Lecithin nanoparticles show promise
We explored a new method for treating breast cancer by using lecithin-based nanoparticles loaded with Palbociclib (PALB). These particles are uniquely designed to release the drug in a pH-sensitive manner, showing promise in lab studies by significantly reducing cancer cell growth compared to Palbociclib alone.
We noted improvements in drug delivery that led to increased cell death and reduced migration of cancer cells. However, while the results are promising, it’s important to conduct further research to confirm these effects in actual clinical settings.
We noted improvements in drug delivery that led to increased cell death and reduced migration of cancer cells. However, while the results are promising, it’s important to conduct further research to confirm these effects in actual clinical settings.
References
- Banerjee S, Mukhopadhyay S, Das A, Banerjee S, Bose S, et al. Preparation, characterisation, anticancer potential and safety evaluation of a soy lecithin phytosome delivery system loaded with constituents from . J Microencapsul. 2025. doi:10.1080/02652048.2025.2467046
- Al-Baidhani SAS, Pouresmaeil V, Homayouni Tabrizi M. Synthesis of liposomal nanoparticles to load 4-farnesyloxycoumarin and investigating its anti-cancer and anti-metastatic effects. J Liposome Res. 2024. doi:10.1080/08982104.2024.2428168
- Villegas-Aguilar MDC, Cádiz-Gurrea ML, Salumets A, Arráez-Román D, Segura-Carretero A, et al. Targeted breast cancer therapy using novel nanovesicle formulations of Olea europaea extract. Biomed Pharmacother. 2024;180:117583. doi:10.1016/j.biopha.2024.117583
- Pooja YS, Rajana N, Yadav R, Naraharisetti LT, Godugu C, et al. Design, development, and evaluation of CDK-4/6 inhibitor loaded 4-carboxy phenyl boronic acid conjugated pH-sensitive chitosan lecithin nanoparticles in the management of breast cancer. Int J Biol Macromol. 2024;258:128821. doi:10.1016/j.ijbiomac.2023.128821
- Ahmed SA, Gaber MH, Salama AA, Ali SA. Efficacy of copper nanoparticles encapsulated in soya lecithin liposomes in treating breast cancer cells (MCF-7) in vitro. Sci Rep. 2023;13:15576. doi:10.1038/s41598-023-42514-2
- Vatansever O, Bahadori F, Bulut S, Eroglu MS. Coating with cationic inulin enhances the drug release profile and in vitro anticancer activity of lecithin-based nano drug delivery systems. Int J Biol Macromol. 2023;237:123955. doi:10.1016/j.ijbiomac.2023.123955
- Shinde VR, Khatun S, Thanekar AM, Hak A, Rengan AK. Lipid-coated red fluorescent carbon dots for imaging and synergistic phototherapy in breast cancer. Photodiagnosis Photodyn Ther. 2023;41:103314. doi:10.1016/j.pdpdt.2023.103314
- Ramzy A, ElSafy S, Elshoky HA, Soliman A, Youness R, et al. Drugless nanoparticles tune-up an array of intertwined pathways contributing to immune checkpoint signaling and metabolic reprogramming in triple-negative breast cancer. Biomed Mater. 2022;18. doi:10.1088/1748-605X/aca85d
- Ahmed MM, Anwer MK, Fatima F, Aldawsari MF, Alalaiwe A, et al. Boosting the Anticancer Activity of Sunitinib Malate in Breast Cancer through Lipid Polymer Hybrid Nanoparticles Approach. Polymers (Basel). 2022;14. doi:10.3390/polym14122459
- Liang M, Guo M, Saw PE, Yao Y. Fully Natural Lecithin Encapsulated Nano-Resveratrol for Anti-Cancer Therapy. Int J Nanomedicine. 2022;17:2069. doi:10.2147/IJN.S362418
- Taghizadeh MS, Niazi A, Moghadam A, Afsharifar A. Experimental, molecular docking and molecular dynamic studies of natural products targeting overexpressed receptors in breast cancer. PLoS One. 2022;17:e0267961. doi:10.1371/journal.pone.0267961
- Zafar A, Alruwaili NK, Imam SS, Alsaidan OA, Ahmed MM, et al. Development and Optimization of Hybrid Polymeric Nanoparticles of Apigenin: Physicochemical Characterization, Antioxidant Activity and Cytotoxicity Evaluation. Sensors (Basel). 2022;22. doi:10.3390/s22041364
- Wu W, Yang Y, Liang Z, Song X, Huang Y, et al. Near infrared II laser controlled free radical releasing nanogenerator for synergistic nitric oxide and alkyl radical therapy of breast cancer. Nanoscale. 2021;13:11169. doi:10.1039/d1nr01859k
- Zou Y, Wang X, Bi D, Fu J, Han J, et al. Pterostilbene nanoparticles with small particle size show excellent anti-breast cancer activityand. Nanotechnology. 2021;32. doi:10.1088/1361-6528/abfdec
- Hasan M, Elkhoury K, Belhaj N, Kahn C, Tamayol A, et al. Growth-Inhibitory Effect of Chitosan-Coated Liposomes Encapsulating Curcumin on MCF-7 Breast Cancer Cells. Mar Drugs. 2020;18. doi:10.3390/md18040217
- Li J, Elkhoury K, Barbieux C, Linder M, Grandemange S, et al. Effects of Bioactive Marine-Derived Liposomes on Two Human Breast Cancer Cell Lines. Mar Drugs. 2020;18. doi:10.3390/md18040211
